Conditions: Overactive Bladder Syndrome
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 947
Healthy volunteers: no

Brief summary:
To evaluate the efficacy and safety of fesoterodine on overactive bladder symptom improvement when added to ongoing alpha blocker treatment.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Fesoterodine intervention 2: Placebo
Intervention descriptions: intervention 1: Fesoterodine 4mg or 8mg intervention 2: Placebo

Protocol document: